Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
Identifieur interne : 003358 ( Main/Merge ); précédent : 003357; suivant : 003359Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
Auteurs : P. Richard Schuurman [Pays-Bas] ; D. Andries Bosch [Pays-Bas] ; Maruschka P. Merkus [Pays-Bas] ; Johannes D. Speelman [Pays-Bas]Source :
- Movement Disorders [ 0885-3185 ] ; 2008-06-15.
English descriptors
- KwdEn :
- Aged, Deep Brain Stimulation, Essential Tremor (therapy), Female, Follow-Up Studies, Humans, Male, Middle Aged, Multiple Sclerosis (therapy), Neurologic Examination, Parkinson, Parkinson Disease (therapy), Thalamus (physiopathology), Thalamus (surgery), essential tremor, multiple sclerosis, thalamic stimulation, thalamotomy, tremor.
- MESH :
- physiopathology : Thalamus.
- surgery : Thalamus.
- therapy : Essential Tremor, Multiple Sclerosis, Parkinson Disease.
- Aged, Deep Brain Stimulation, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neurologic Examination.
Abstract
Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.
Url:
DOI: 10.1002/mds.22059
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001A60
- to stream Istex, to step Curation: 001A60
- to stream Istex, to step Checkpoint: 001336
- to stream PubMed, to step Corpus: 002251
- to stream PubMed, to step Curation: 002251
- to stream PubMed, to step Checkpoint: 002232
- to stream Ncbi, to step Merge: 002110
- to stream Ncbi, to step Curation: 002110
- to stream Ncbi, to step Checkpoint: 002110
Links to Exploration step
ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25BLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22059</idno><idno type="url">https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001A60</idno><idno type="wicri:Area/Istex/Curation">001A60</idno><idno type="wicri:Area/Istex/Checkpoint">001336</idno><idno type="wicri:doubleKey">0885-3185:2008:Schuurman P:long:term:follow</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:18442104</idno><idno type="wicri:Area/PubMed/Corpus">002251</idno><idno type="wicri:Area/PubMed/Curation">002251</idno><idno type="wicri:Area/PubMed/Checkpoint">002232</idno><idno type="wicri:Area/Ncbi/Merge">002110</idno><idno type="wicri:Area/Ncbi/Curation">002110</idno><idno type="wicri:Area/Ncbi/Checkpoint">002110</idno><idno type="wicri:Area/Main/Merge">003358</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurology, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-06-15">2008-06-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1146">1146</biblScope><biblScope unit="page" to="1153">1153</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno><idno type="DOI">10.1002/mds.22059</idno><idno type="ArticleID">MDS22059</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Deep Brain Stimulation</term><term>Essential Tremor (therapy)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Multiple Sclerosis (therapy)</term><term>Neurologic Examination</term><term>Parkinson</term><term>Parkinson Disease (therapy)</term><term>Thalamus (physiopathology)</term><term>Thalamus (surgery)</term><term>essential tremor</term><term>multiple sclerosis</term><term>thalamic stimulation</term><term>thalamotomy</term><term>tremor</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Thalamus</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Thalamus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Essential Tremor</term><term>Multiple Sclerosis</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Deep Brain Stimulation</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neurologic Examination</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="fr">Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</div></front></TEI><double doi="10.1002/mds.22059"><ISTEX><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1002/mds.22059</idno><idno type="url">https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001A60</idno><idno type="wicri:Area/Istex/Curation">001A60</idno><idno type="wicri:Area/Istex/Checkpoint">001336</idno><idno type="wicri:doubleKey">0885-3185:2008:Schuurman P:long:term:follow</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name><affiliation wicri:level="3"><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurology, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2008-06-15">2008-06-15</date><biblScope unit="vol">23</biblScope><biblScope unit="issue">8</biblScope><biblScope unit="page" from="1146">1146</biblScope><biblScope unit="page" to="1153">1153</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno><idno type="DOI">10.1002/mds.22059</idno><idno type="ArticleID">MDS22059</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson</term><term>essential tremor</term><term>multiple sclerosis</term><term>thalamic stimulation</term><term>thalamotomy</term><term>tremor</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="fr">Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</div></front></TEI></ISTEX><PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression.</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P Richard" last="Schuurman">P Richard Schuurman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands. p.r.schuurman@amc.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D Andries" last="Bosch">D Andries Bosch</name></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P" last="Merkus">Maruschka P. Merkus</name></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D" last="Speelman">Johannes D. Speelman</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2008">2008</date><idno type="doi">10.1002/mds.22059</idno><idno type="RBID">pubmed:18442104</idno><idno type="pmid">18442104</idno><idno type="wicri:Area/PubMed/Corpus">002251</idno><idno type="wicri:Area/PubMed/Curation">002251</idno><idno type="wicri:Area/PubMed/Checkpoint">002232</idno><idno type="wicri:Area/Ncbi/Merge">002110</idno><idno type="wicri:Area/Ncbi/Curation">002110</idno><idno type="wicri:Area/Ncbi/Checkpoint">002110</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Long-term follow-up of thalamic stimulation versus thalamotomy for tremor suppression.</title><author><name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P Richard" last="Schuurman">P Richard Schuurman</name><affiliation wicri:level="3"><nlm:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands. p.r.schuurman@amc.nl</nlm:affiliation><country xml:lang="fr">Pays-Bas</country><wicri:regionArea>Department of Neurosurgery, Academic Medical Center, Amsterdam</wicri:regionArea><placeName><settlement type="city">Amsterdam</settlement><region nuts="2" type="province">Hollande-Septentrionale</region></placeName></affiliation></author><author><name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D Andries" last="Bosch">D Andries Bosch</name></author><author><name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P" last="Merkus">Maruschka P. Merkus</name></author><author><name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D" last="Speelman">Johannes D. Speelman</name></author></analytic><series><title level="j">Movement disorders : official journal of the Movement Disorder Society</title><idno type="eISSN">1531-8257</idno><imprint><date when="2008" type="published">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Deep Brain Stimulation</term><term>Essential Tremor (therapy)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Multiple Sclerosis (therapy)</term><term>Neurologic Examination</term><term>Parkinson Disease (therapy)</term><term>Thalamus (physiopathology)</term><term>Thalamus (surgery)</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Thalamus</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Thalamus</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Essential Tremor</term><term>Multiple Sclerosis</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Deep Brain Stimulation</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Neurologic Examination</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow-up. Sixty-eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow-up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1-7.7) after 6 months, 3.3 (95% CI: -0.03-6.6) after 2 years and 4.0 (95% CI: 0.3-7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment-related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome-assessment by the patients was more favorable in the stimulation group.</div></front></TEI></PubMed></double></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003358 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 003358 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Merge
|type= RBID
|clé= ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B
|texte= Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
}}
| This area was generated with Dilib version V0.6.23. |  |